InvestorsHub Logo
Followers 0
Posts 24
Boards Moderated 0
Alias Born 08/16/2017

Re: None

Friday, 07/27/2018 10:46:09 PM

Friday, July 27, 2018 10:46:09 PM

Post# of 402726
facts about Cellceutix/innovation pharmaceuticals.


At first menon claimed he had a PhD in pharmacology from Harvard, he even stated this in his bio on the company web page.

it was not until after someone contacted Harvard and verifying he was never a student there, that they finally changed the bio.

The truth is Menon is a veterinarian from the carribean. He worked in the animal testing facilities at a pharma, thats it.

There is no basis to "kevetrin" it's ridiculous, people fail to differentiate between "orphan drug" and "orphan drug development", they capitalize on this. At first it was a kinase inhibitor with only millimolar activity then it induces activation of the guardian of the genome, where do they come up with this stuff, its embarrassing. There is no one with any real experience involved with the science.

They made claims a renowned Columbia chemist was on their SAB, when he was asked about Cellceutix, he said he didn't even know them.

He would claim elderly professors long since retired to be on their SAB as well

The FDA shouldn't allow people that lie about their credentials to play the system.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent IPIX News